Liver diseases: what is known so far about the therapy with human amniotic membrane?
- 275 Downloads
Liver, the largest intern organ of the human body, is responsible for several vital tasks such as digestive and excretory functions, as well as for nutrients storage and metabolic functions, synthesis of new molecules and purification of toxic chemicals. Cirrhosis, fibrosis and hepatocellular carcinoma are the most prevalent liver diseases. Despite all the studies performed so far, treatment options for these diseases are very limited. For this reason, it is urgent to find effective therapies for these pathologies. Several studies have been performed during the last decade about the possible application of human amniotic membrane in hepatic diseases therapy. Promising results about human amniotic membrane or its derived cells, in vitro and in vivo, applications in fibrosis, cirrhosis and hepatocellular carcinoma were already published. Since it is an attractive study area, it is becoming a dynamic scientific subject. However, the action mechanisms of human amniotic membrane and its derived cells in hepatic diseases therapy must be precisely known in order that this promising therapy could be clinically used.
KeywordsLiver diseases Fibrosis Cirrhosis Hepatocellular carcinoma Human amniotic membrane
Ana Catarina Mamede (SFRH/BD/73649/2010) and Maria João Carvalho (SFRH/SINTD/60068/2009) wishes to thank to Portuguese Foundation for Science and Technology for their PhD Grants.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
- Adinolfi M, Akle CA, McColl I, Fensom AH, Tansley L, Connolly P, Hsi BL, Faulk WP, Travers P, Bodmer WF (1982) Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 295(5847):325–327Google Scholar
- Ahmed I, Lobo DN (2009) Malignant tumours of the liver. Surgery 27(1):30–37Google Scholar
- Brandão DF, Ramalho LN, Ramalho FS, Zucoloto S, Martinelli Ade L, Silva Ode C (2006) Liver cirrhosis and hepatic stellate cells. Acta Cirúrgica Brasileira 21(1):54–57Google Scholar
- Carlson BM (ed) (2014) “Placenta and extraembryonic membranes.” In: Human embryology and developmental biology. Elsevier, Amsterdam, pp 131–52Google Scholar
- Ferlay J et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [internet]. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr
- Ganong WF (2005) Review of medical physiology (LANGE Basic Science), 22nd edn. McGraw-Hill Medical, New YorkGoogle Scholar
- Gray H, Lewis WH (2000) Gray’s anatomy of the human body, 20th edn. Bartleby, New YorkGoogle Scholar
- Jackson G, Whitfield P (1985) Digestion: fueling the system (Library of the Human Body). Torstar Books, New YorkGoogle Scholar
- Kubo M, Sonoda Y, Muramatsu R, Usui M (2001) Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 42(7):1539–1546Google Scholar
- Lin JS et al (2015) Hepatic differentiation of human amniotic epithelial cells and in vivo therapeutic effect on animal model of cirrhosis. J Gastroenterol Hepatol 30(11):1673–1682Google Scholar
- Mamede AC, Botelho MF (eds) (2015) Amniotic membrane, 1st edn. Springer, NetherlandsGoogle Scholar
- Mamede AC et al (2016) Oxidative stress, DNA, cell cycle/cell cycle associated proteins and multidrug resistance proteins: targets of human amniotic membrane in hepatocellular carcinoma. Pathol Oncol Res (in press)Google Scholar
- McMillan B (2008) The illustrated atlas of the human Body, 1st edn. Weldon Owen Pty Ltd, McMahons PointGoogle Scholar
- Niknejad H et al (2008) Properties of the amniotic membrane for potential use in tissue engineering. Eur Cells Mater 15:88–99Google Scholar
- Seeley R, Stephens T, Tate P (2003) Anatomy and physiology, 6th edn. McGraw-Hill Companies Inc, New YorkGoogle Scholar
- Zhang D, Jiang M, Miao D (2011) Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS ONE 6(2):1–9Google Scholar